Multifaceted HIV integrase functionalities and therapeutic strategies for their inhibition.
Ontology highlight
ABSTRACT: Antiretroviral inhibitors that are used to manage HIV infection/AIDS predominantly target three enzymes required for virus replication: reverse transcriptase, protease, and integrase. Although integrase inhibitors were the last among this group to be approved for treating people living with HIV, they have since risen to the forefront of treatment options. Integrase strand transfer inhibitors (INSTIs) are now recommended components of frontline and drug-switch antiretroviral therapy formulations. Integrase catalyzes two successive magnesium-dependent polynucleotidyl transferase reactions, 3' processing and strand transfer, and INSTIs tightly bind the divalent metal ions and viral DNA end after 3' processing, displacing from the integrase active site the DNA 3'-hydroxyl group that is require
SUBMITTER: Engelman AN
PROVIDER: S-EPMC6791320 | biostudies-literature | 2019 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA